Bad faith is an ever-evolving doctrine in trademark law, which has seen several recent developments in key jurisdictions for brand owners. This webinar will cover perspectives from the US, China and Europe, with a focus on case studies and practical take-aways.

This presentation by Carole Boelitz and Jason Friday at Lenovo, moderated by Ahsan Shaikh at McDermott, will discuss the challenges and rewards of taking this bold step into transparency in the diversity in innovation discussion, and what other organizations can do to follow in the Lenovo’s footsteps

With the pandemic, remote and hybrid work arrangements, including for IP lawyers, has proliferated. As we look ahead to re-entry after the pandemic – even if delayed – it appears that such arrangements will continue, at least to some degree, alongside in-person arrangements. This virtual panel discussion will cover topics relating to the various work arrangements, with a focus on those with disabilities.

This joint webinar will provide an overview of arbitration and mediation of IP disputes. Speakers from private practice in the U.S. and China will discuss mechanisms, experiences, and insights for requesting and conducting alternative dispute resolution in their respective countries. In addition, a WIPO official will join the panel to discuss the details of using the WIPO Arbitration and Mediation Center as a venue to resolve disputes.

Joint ventures (JVs) and other collaborations are becoming increasingly important across the energy sector. They can help lower costs, spread risk, meet technical challenges, open new markets, and navigate ongoing price volatility. But JVs and other collaborations also create many potential pitfalls for your IP portfolio.

The Diverse Inventors subcommittee of the Women in IP Committee is proud to launch a new and updated Law Firm Toolkit that assists legal professionals in law firms to team with their corporate and university clients to increase the diversity in in the innovation ecosphere of the their clients.  The panel will walk through the updated toolkit, how to use it, and discuss practical ways for in-house and outside counsel to partner to use the toolkit.

IPO’s Diversity & Inclusion committee is excited to announce the launch of the newest version 3.0 of its Practical Guide to Diversity & Inclusion in the Legal Profession. This new version is being released in easily digestible sections with accompanying webinars. The first webinar introducing Section 101 of the Guide is scheduled for July 20. This webinar will cover the basics of Diversity & Inclusion within the legal profession - especially the IP profession. Additional webinars discussing additional sections of the Guide will be announced in the coming weeks. 

This webinar will provide a roundup of this year’s most significant intellectual property cases. Our panelists are three litigators in private practice, all members of IPO’s Amicus Brief Committee. They will review the most significant decisions as of June 30 and give a sneak peek at coming attractions.

This webinar will share information about the status of the various TRIPS waiver proposals, the logistics of negotiations at the WTO, and the roles of various U.S. governmental and international agencies. Our esteemed panel will discuss questions such as whether a waiver would actually increase access to vaccines and other technologies, the impact of a waiver on innovation, impediments to ensuring broader vaccine access, and the effectiveness of ongoing voluntary efforts to distribute the vaccine and other important technologies more widely.

In May, the Brazilian Supreme Court issued a landmark decision declaring unconstitutional the 10-year minimum patent term guarantee. The decision impacts more than 30,000 pending patent applications and patents. In addition, the Supreme Court ruled that the decision applies retroactively to pharmaceuticals and medical device patents. Brazilian Patent and Trademark Office (BRPTO) is already notifying patent holders of the reduction of the patent term in each affected patent. The Supreme Court decision represents a major change in the Brazilian Patent System.

This webinar will cover the status of the legislation, details on how CBP uses its existing authority is used for trademark and trade dress enforcement, and provide examples of how design can be used by right holders to combat counterfeiting.  Speakers will also discuss how other countries enforce design patents at their borders and answer questions during a Q&A session at the end.

The process of getting your corporation’s diversity in innovation metrics sounds simple until you actually try to do it. This panel will walk the audience through the practical steps of how to generate data indicating the extent of gender diversity amongst an entity's inventor community.

The duty of disclosure before the U.S. Patent Office and the associated defense of inequitable conduct in the courts are ones for which patent practitioners must constantly stay knowledgeable. While some things remain constant with the duty and defense, nuances continuously evolve. This panel brings a perspective from both the litigators’ and prosecutors’ points of view, with particular focus on the state of the law after GS Cleantech, the nuanced differences between the scope of the duty of disclosure between different Patent Office forums, and best practices and tips from the patent prosecutor’s perspective.

This webinar, which is part of our European Practice Webinar Series, will address whether, following the Decision G 1/19 on Computer-implemented simulations, something has changed with respect to the assessment of patentability and inventiveness in Europe. In this long-awaited decision, the Enlarged Board of Appeal (EBOA) of the European Patent Office concluded that computer-implemented simulations should be treated under the long-standing COMVIK approach for Computer-Implemented Inventions (CII) and can be technical.

The webinar will explore this issue from a legal and policy perspective, and discuss the voluntary IP licensing initiatives taken by companies in the pharmaceutical, medical device and IT industries in meeting the challenges of the current pandemic.​